Journal profile · Clinical Neurology
NEUROLOGIST
ISSN 1074-7931 · eISSN 2331-2637 · Lippincott Williams and Wilkins Ltd. · UNITED STATES · Bimonthly · Founded 1995
NEUROLOGIST: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.16; JCR Q4 (journal website); hybrid open access; median 146 days to acceptance (36 articles, last 24 months); community-reported acceptance: about 75%; 42 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
NEUROLOGIST is published by Lippincott Williams and Wilkins Ltd. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Acute Ischemic Stroke Management, Epilepsy research and treatment and Cerebrovascular and Carotid Artery Diseases, together about 23.3% of its articles. Its main subfields are Neurology. (generated from OpenAlex topic counts and CAS ranking data)
Stroke is a leading cause of mortality and disability worldwide, particularly acute ischemic stroke (AIS) due to large vessel occlusion (LVO). Although endovascular intervention has proven effective, individual outcomes vary considerably. This study aimed to identify key prognostic factors and develop a predictive model for neurological recovery in patients with LVO-AIS following endovascular thrombectomy (EVT).
From the journal's Aims & Scope
Research area (LetPub): Clinical Neurology
Editor-in-chief Bart M. DemaerschalkPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Acute Ischemic Stroke ManagementMedicine10.5%
- Epilepsy research and treatmentMedicine6.5%
- Cerebrovascular and Carotid Artery DiseasesMedicine6.3%
- Intracerebral and Subarachnoid Hemorrhage ResearchMedicine5.2%
- Peripheral Neuropathies and DisordersMedicine4.9%
- Multiple Sclerosis Research StudiesMedicine4.8%
- Neurological Complications and SyndromesMedicine4.7%
- Intracranial Aneurysms: Treatment and ComplicationsMedicine4.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Clinical Neurology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Clinical Neurology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Clinical Neurology | Zone 4 |
Top journal: noReview journal: no
JCR / CiteScore quartiles on the journal's website
- JCR Q4 · CLINICAL NEUROLOGY · rank 250/296
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.16LetPub ·
- Impact factor (publisher)
- 1.2Publisher website ·
- CiteScore 2026-06
- 2.1LetPub ·
- SJR 2026-06
- 0.35LetPub ·
- SNIP 2026-06
- 0.51LetPub ·
- h-index
- 55LetPub ·
- h-index
- 78OpenAlex ·
- i10-index
- 660OpenAlex ·
- 2-year mean citedness
- 1.21OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 15.42%LetPub ·
Volume
- Articles per year
- 60LetPub ·
Articles by year OpenAlex count · 1,704 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 42 | 10 | 9 |
| 2025 | 42 | 7 | 37 |
| 2024 | 57 | 7 | 124 |
| 2023 | 65 | 25 | 200 |
| 2022 | 73 | 19 | 391 |
| 2021 | 102 | 28 | 576 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
146 daysMedian, submission to acceptance · P25–P75 124 days – 198 days
- Acceptance to online
- median 86 days (36 articles)
- Submission to online
- median 247 days
- Sample
- 36 articles with submission and acceptance dates (120 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 2 monthsLetPub ·
- Average acceptance (community reports)
- 75%LetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Lippincott Williams and Wilkins Ltd.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1995
- ISSN
- 1074-7931
- Electronic ISSN
- 2331-2637
- Latest issue on the website
- Volume 31, Issue 5 (September 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about NEUROLOGIST
What CAS zone is NEUROLOGIST in?
In the 2025 upgraded edition of the CAS Journal Ranking, NEUROLOGIST is in Zone 4 of Medicine, and in Zone 4 of the minor category Clinical Neurology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of NEUROLOGIST?
The latest impact factor listed by LetPub is 1.16; CiteScore 2.1, h-index 78.
How long does peer review take at NEUROLOGIST?
Based on the dates recorded on 36 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 146 days (interquartile range 124–198 days); authors report an average review time of about 2 months; the community-reported acceptance is “about 75%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is NEUROLOGIST in?
The journal's website gives JCR Q4; by category, CLINICAL NEUROLOGY Q4 (250/296). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 4 of Medicine.
Which databases index NEUROLOGIST?
According to LetPub and DOAJ records, NEUROLOGIST is indexed in SCIE and Scopus.
Is NEUROLOGIST open access, and what is the APC?
NEUROLOGIST is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .